Trials / Completed
CompletedNCT05137093
Scratching Validation Study
Independent Validation Study of Nighttime Scratching Quantification With Actigraphy in Adults With Atopic Dermatitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (actual)
- Sponsor
- Philips Clinical & Medical Affairs Global · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
Single center, analyst-blinded, study comparing the scratching events identified via an actigraphy scoring algorithm versus manual scoring of an overnight video recording, undertaken in a sample of 40 adult patients with atopic dermatitis and controls.
Detailed description
The Philips scratching algorithm has been cross-validated against the gold-standard assessment of scratching. The algorithm has been used in many drug development trials, occasionally as a means of generating secondary endpoints, but most often as a means of generating exploratory endpoints. The purpose of the proposed study is therefore to validate the data generated by the scratching study compared to the gold-standard video-assessment of scratching, in an independent sample of adults with atopic dermatitis and age- and sex-matched controls
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Actigraphy Device | Patients will wear actigraphy device which detects scratching events. |
Timeline
- Start date
- 2021-12-10
- Primary completion
- 2023-02-01
- Completion
- 2023-02-01
- First posted
- 2021-11-30
- Last updated
- 2023-03-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05137093. Inclusion in this directory is not an endorsement.